Botanical Forum
BOTANICAL DRUG DISCOVERY: Breakthroughs in polymolecular therapeutics
November 15, 2010
This one-day science forum, co-sponsored by Afexa Life Sciences, featured experts from Canada, the US and abroad, and highlighted recent research discoveries and regulatory perspectives in the polymolecular drug development field.
Forum Speakers
Opening remarks
| Dr. Bhagirath Singh: | Forum Chair |
| Mr. Peter Brenders: | Keynote Session Chair |
Keynote Address
| Dr. Erminia Guarneri: | Personalized, Predictive, Proactive Health: Treating the Whole Person, Body, Mind & Spirit |
The advantages of polymolecular drugs, pitfalls of single chemical therapeutics
| Dr. Stephen Sagar: | Session Chair |
| Dr. Jacqueline Shan: | Standardization of botanical drugs |
| Dr. Peter Hylands: | Development of novel standardization methods for Traditional Chinese Medicine |
| Dr. Scot Purdon: | American ginseng to reduce risk of coronary heart disease associated with severe mental illness |
Novel polymolecular drug formulations for metabolic health
| Dr. Mary Hardy: | Session Chair |
| Dr. Richard Lewanczuk: | Lipid modulation in slightly-at-risk adults: More of the good and less of the bad |
| Dr. Grant Pierce: | The use of a novel nutraceuticaldecoction for the long term treatment of Type 1 diabetes |
| Dr. Pierre Haddad: | Translating aboriginal traditional knowledge into scientific evidence: Novel anti-obesity and anti-diabetic remedies from the Canadian Boreal forest |
Applications for polymolecular drugs in immunotherapy and cancer
| Dr. Ken Rosenthal: | Session Chair |
| Dr. Ed Shaw: | North American ginseng as an immunomodulator in patients with Chronic Lymphocytic Leukemia |
| Dr. Aurodel Giglio: | The effects of Paulinia cupana (guaraná) on Cancer related Fatigue |
| Dr. Ken Rosenthal: | Modulation of Toll-like receptors (TLRs) – putative multi-therapeutic applications |
Polymolecular drug discovery: Current landscapes and future directions
| Dr. Alastair Summerlee: | Session Chair |
| Dr. Jeffrey White: | The US National Institute and Botanicals Research |
| Ms. Lucie Dufour, LLB: | Natural Health Products – What’s New and Pharmacovigilance Requirements |
| Dr. Jay Udani: | Clinical Trial Design for Natural Health Products |
| Dr. Freddie Ann Hoffman: | Developing naturally polymolecular health products – a novel drug category for the United States |
Concluding remarks
| Dr. Bhagirath Singh: | Forum Chair |